Delivery Order SPE2DR25D2101-SPE2DR26F46PP
- Not listed
- The Defense Logistics Agency awarded a $1,702.44 delivery order to AmerisourceBergen Drug Corp for Terbinafine HCL 250 mg tablets (30-count packaging) on December 15, 2025, with completion targeted for December 16, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and will be performed at the contractor's Conshohocken, Pennsylvania location. The order is issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for Terbinafine HCL 250 mg tablets (30-count package) valued at $1,057.00. This is a firm fixed price delivery order with no set-aside designation, indicating the award was made through open competition. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of December 10, 2025. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $3,722.99 to AmerisourceBergen Drug Corp for the supply of Terbinafine HCL 250 mg tablets (30-count units). This is a firm fixed-price, non-set-aside contract with performance expected to be completed by August 11, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location in the same city. The delivery order represents...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Terbinafine HCL 250 mg tablets (30-count units) with a ceiling value of $1,808.77. This competitively awarded, firm fixed-price delivery order was issued on December 16, 2025, with an ultimate completion date of December 17, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,430.69 to AmerisourceBergen Drug Corp for Terbinafine HCL 250 mg tablets (30-count) on December 9, 2025, with completion scheduled for December 10, 2025. This contract represents a firm fixed-price delivery order with no set-aside designation, awarded competitively to the prime contractor. The award is executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX),...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Terbinafine HCL 250 mg tablets (30-count) on December 16, 2025, with a ceiling value of $1,749.89 and ultimate completion date of December 17, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside contract action sourced from AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at approximately $1 billion through...
- The Defense Logistics Agency awarded a $2,123.41 delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Terbinafine HCL 250 mg tablets in quantities of 30. The contract, which is a firm fixed price delivery order with no set-aside designation, represents a competitively awarded procurement supporting federal medical supply needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Terbinafine HCL 250 mg tablets in quantities of 100s, with a ceiling value of $11,707.25. The delivery order represents a firm fixed price, competitive award with no set-aside designation and an ultimate completion date of September 17, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location....
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,838.56 for Terbinafine HCL 250 mg tablets (90-count units) on October 28, 2025, with an ultimate completion date of October 29, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a single delivery order issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Terbinafine HCL 250 mg tablets in quantities of 30, with a ceiling value of $7,207.59. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and is scheduled for completion by September 17, 2025. AmerisourceBergen's place of performance is located in Conshohocken, Pennsylvania, reflecting the company's headquarters location and...
- SPE2DR25D2101Indefinite Delivery Contract
- SPE2DR25D2101-SPE2DR26F46PPDelivery Order
The Defense Logistics Agency awarded a $1,116.74 delivery order to AmerisourceBergen Drug Corp for Terbinafine HCL 250 mg tablets (90-count units) on December 17, 2025, with completion expected by December 18, 2025. This firm fixed-price delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The delivery order is unclassified as a set-aside and represents a competitively awarded transaction for pharmaceutical supply to federal medical procurement needs. Performance will be conducted at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal military and veteran healthcare systems through its comprehensive portfolio with the Defense Logistics Agency. The company's SPE2DX contract functions as a global pharmaceutical support vehicle enabling delivery of a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. This particular terbinafine order exemplifies the company's role in supplying generic medications and specialized pharmaceuticals across multiple therapeutic domains to support Defense Health Agency requirements and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 12/16/25 |